Published in Rev Urol on January 01, 2011
Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study. Res Rep Urol (2015) 0.78
Penile traction therapy for Peyronie's disease-what's the evidence? Transl Androl Urol (2016) 0.75
Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application. Res Rep Urol (2017) 0.75
The natural history of Peyronie's disease. J Urol (1990) 2.02
A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol (2009) 1.91
Retracted A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease. BJU Int (2009) 1.70
A critical analysis of nonsurgical treatment of Peyronie's disease. Eur Urol (2006) 1.67
Penile sonographic and clinical characteristics in men with Peyronie's disease. J Sex Med (2009) 1.55
The natural history of Peyronie's disease: an ultrasonography-based study. Eur Urol (2007) 1.54
Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial. J Sex Med (2010) 1.53
Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study. J Sex Med (2007) 1.51
Investigation of the antifibrotic effect of IFN-gamma on fibroblasts in a cell culture model of Peyronie's disease. Eur Urol (2007) 1.47
Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol (2002) 1.44
Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach. J Urol (2004) 1.43
Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study. J Sex Med (2008) 1.08
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol (1993) 1.08
Intralesional verapamil injection for the treatment of Peyronie's disease. J Urol (1994) 1.05
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. J Urol (2004) 1.05
Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. J Sex Med (2008) 1.04
Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. Int J Impot Res (2004) 1.03
Treatment of Peyronie's disease with oral pentoxifylline. Nat Clin Pract Urol (2006) 1.03
The use of collagenase in the treatment of Peyronie's disease. J Urol (1985) 1.02
The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study. J Sex Med (2008) 1.02
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol (2007) 1.02
Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Eur Urol (2005) 1.01
Peyronie's disease: etiology, medical, and surgical therapy. J Androl (2000) 0.99
Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol (1999) 0.96
Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int (2001) 0.94
Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol (2002) 0.94
Critical analysis of surgery for Peyronie's disease. Curr Opin Urol (2004) 0.93
Management of Peyronie's disease--a review. World J Urol (2001) 0.91
Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses. Int J Impot Res (2002) 0.91
Defining the clinical characteristics of Peyronie's disease in young men. J Sex Med (2006) 0.88
Subclinical Peyronie's disease. Am J Clin Pathol (1969) 0.86
Intralesional verapamil prevents the progression of Peyronie's disease. Urology (2007) 0.85
International Conference on Peyronie's disease advances in basic and clinical research. March 17-19, 1993. Introduction. J Urol (1997) 0.84
Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol (1991) 0.84
New sonographic aspects of peyronie disease. J Ultrasound Med (2009) 0.83
Extracorporal shock wave therapy in the treatment of Peyronie's disease. First results of a case-controlled approach. Eur Urol (2000) 0.82
Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study. Int J Impot Res (2010) 0.80
Tunica albuginea tissue analysis after electromotive drug administration. J Urol (2003) 0.80
Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A prospective, randomized, double-blind placebo-controlled study. J Sex Med (2009) 0.80
Treatment of Peyronie's disease with local interferon-alpha 2b. Eur Urol (1995) 0.80
Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease? J Urol (2010) 0.80
Risk factors of Peyronie's disease. What does our clinical experience show? J Sex Med (2010) 0.79
Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol (1997) 0.79
Extracorporeal shock wave therapy in the treatment of Peyronie's disease: long-term results. Arch Ital Urol Androl (2010) 0.79
Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease. J Pak Med Assoc (2010) 0.78
Peyronle's disease: cortisone-hyaluronidase-hydrocortisone therapy. J Urol (1954) 0.77
Penile traction therapy in Peyronie's disease. F1000 Med Rep (2009) 0.76
The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res (2012) 2.94
ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res (2010) 2.79
ConsensusPathDB--a database for integrating human functional interaction networks. Nucleic Acids Res (2008) 2.77
A gene expression map of human chromosome 21 orthologues in the mouse. Nature (2002) 2.76
Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res (2010) 2.61
Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res (2004) 2.29
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics (2011) 2.24
Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells (2006) 2.18
Postureteroscopic lesion scale: a new management modified organ injury scale--evaluation in 435 ureteroscopic patients. J Endourol (2012) 2.15
A prospective evaluation of pain associated with stone passage, stents, and stent removal using a visual analog scale. Urology (2013) 2.05
International multicentre psychometric evaluation of patient-reported outcome data for the treatment of Peyronie's disease. BJU Int (2015) 2.03
Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol (2011) 1.71
Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells (2005) 1.68
New evidence for genome-wide duplications at the origin of vertebrates using an amphioxus gene set and completed animal genomes. Genome Res (2003) 1.65
Kidney fusion anomalies revisited: clinical and radiological analysis of 209 cases of crossed fused ectopia and horseshoe kidney. BJU Int (2008) 1.61
Longitudinal dorsal dartos flap for prevention of fistula after a Snodgrass hypospadias procedure. Eur Urol (2006) 1.57
Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol (2011) 1.49
Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics (2011) 1.46
Penile length and girth restoration in severe Peyronie's disease using circular and longitudinal grafting. BJU Int (2012) 1.44
Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. Urology (2013) 1.44
Predictive power of objectivation of phimosis grade on outcomes of topical 0.1% betamethasone treatment of phimosis. Urology (2012) 1.42
MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics (2013) 1.38
EAU guidelines on iatrogenic trauma. Eur Urol (2012) 1.34
Challenging surgical management of a giant inguinoscrotal hernia: report of a case. Surg Today (2010) 1.32
EAU Guidelines on Urethral Trauma. Eur Urol (2010) 1.29
Proteomic and functional analysis of the mitotic Drosophila centrosome. EMBO J (2010) 1.27
Reverse engineering of gene regulatory networks: a comparative study. EURASIP J Bioinform Syst Biol (2009) 1.22
Evidence mining and novelty assessment of protein-protein interactions with the ConsensusPathDB plugin for Cytoscape. Bioinformatics (2010) 1.19
A global view of gene expression in lithium and zinc treated sea urchin embryos: new components of gene regulatory networks. Genome Biol (2007) 1.19
Cross-species hybridisation of human and bovine orthologous genes on high density cDNA microarrays. BMC Genomics (2004) 1.16
Resources, standards and tools for systems biology. Brief Funct Genomic Proteomic (2007) 1.15
Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int (2007) 1.15
DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer. PLoS Genet (2013) 1.13
GeNGe: systematic generation of gene regulatory networks. Bioinformatics (2009) 1.11
Generation, annotation, evolutionary analysis, and database integration of 20,000 unique sea urchin EST clusters. Genome Res (2003) 1.11
In silico identification of a core regulatory network of OCT4 in human embryonic stem cells using an integrated approach. BMC Genomics (2009) 1.09
External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery. World J Urol (2010) 1.08
Meta-analysis approach identifies candidate genes and associated molecular networks for type-2 diabetes mellitus. BMC Genomics (2008) 1.08
Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC). BJU Int (2013) 1.07
Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol (2005) 1.05
Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol (2007) 1.04
Nodal signaling activates differentiation genes during zebrafish gastrulation. Dev Biol (2007) 1.03
Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicol Sci (2011) 1.02
Transformation and other factors of the peptide mass spectrometry pairwise peak-list comparison process. BMC Bioinformatics (2005) 1.01
Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell (2006) 1.01
Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics (2011) 1.00
Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells. PLoS Comput Biol (2011) 0.99
Conserved molecular portraits of bovine and human blastocysts as a consequence of the transition from maternal to embryonic control of gene expression. Physiol Genomics (2007) 0.99
A second generation radiation hybrid map to aid the assembly of the bovine genome sequence. BMC Genomics (2006) 0.99
RNA-Seq provides new insights in the transcriptome responses induced by the carcinogen benzo[a]pyrene. Toxicol Sci (2012) 0.98
Expression profiling and comparative genomics identify a conserved regulatory region controlling midline expression in the zebrafish embryo. Genome Res (2004) 0.98
alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int (2007) 0.97
Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int (2008) 0.95
ARH: predicting splice variants from genome-wide data with modified entropy. Bioinformatics (2009) 0.95
LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun (2013) 0.94
DEFOG: a practical scheme for deciphering families of genes. Genomics (2002) 0.92
Correlation of leukocytospermia with clinical infection and the positive effect of antiinflammatory treatment on semen quality. Fertil Steril (2006) 0.89
Simulation of DNA array hybridization experiments and evaluation of critical parameters during subsequent image and data analysis. BMC Bioinformatics (2002) 0.88
Dynamics of biological systems: role of systems biology in medical research. Expert Rev Mol Diagn (2006) 0.88
IntScore: a web tool for confidence scoring of biological interactions. Nucleic Acids Res (2012) 0.88
Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models. Carcinogenesis (2013) 0.87
Cluster-based assessment of protein-protein interaction confidence. BMC Bioinformatics (2012) 0.87
The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability. World J Urol (2013) 0.86
Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. Biomark Med (2014) 0.86
Ureteric replacement with Meckel's diverticulum. BJU Int (2006) 0.86
Gene polymorphisms and prostate cancer: the evidence. BJU Int (2009) 0.86
Complications and long-term outcome of primary obstructive megaureter in childhood. Pediatr Nephrol (2010) 0.86
Prediction in the face of uncertainty: a Monte Carlo-based approach for systems biology of cancer treatment. Mutat Res (2012) 0.85
Synchronous bilateral malignant mesothelioma of tunica vaginalis testis: early diagnosis. Urology (2004) 0.84
Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? BJU Int (2008) 0.84
DIPSBC--data integration platform for systems biology collaborations. BMC Bioinformatics (2012) 0.84
Oxidative stress and epididymal sperm transport, motility and morphological defects. Eur J Obstet Gynecol Reprod Biol (2009) 0.83
PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy. World J Urol (2010) 0.82
Molecular characterization of cultured adult human liver progenitor cells. Tissue Eng Part C Methods (2010) 0.82
Urinary continence after radical prostatectomy: the patient perspective. Can J Urol (2011) 0.81
Case report: laparoscopic ureteropyelostomy and distal ureterectomy for management of duplication with ectopia. J Endourol (2007) 0.80
Development and application of a DNA microarray-based yeast two-hybrid system. Nucleic Acids Res (2012) 0.80
Infantile Enuresis: Current State-of-the-Art Therapy and Future Trends. Rev Urol (2011) 0.80
Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer: a three-color/five-parameter flow cytometric study on peripheral blood samples. Am J Clin Pathol (2008) 0.80
Urinary acetonitrile concentrations correlate with recent smoking behaviour. BJU Int (2005) 0.80
Effects of local estrogen therapy on recurrent urinary tract infections in young females under oral contraceptives. Eur Urol (2005) 0.79
Gene ontology analysis of the centrosome proteomes of Drosophila and human. Commun Integr Biol (2011) 0.79
Elevated levels of carbonyl proteins in cerebrospinal fluid of patients with neurodegenerative diseases. Tohoku J Exp Med (2014) 0.78
Construction of a pig physical interactome using sequence homology and a comprehensive reference human interactome. Evol Bioinform Online (2012) 0.78
Multiplexed hybridizations of positively charge-tagged peptide nucleic acids detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2004) 0.78
Glans reconstruction with the use of an inverted urethral flap after distal penile amputation for carcinoma. Arch Ital Urol Androl (2013) 0.78
Power Doppler ultrasound imaging for quantification of urinary bladder neck blood flow changes. Ultrasound Med Biol (2004) 0.77
Survival in prostate cancer patients > or = 70 years after radical prostatectomy and comparison to younger patients. World J Urol (2009) 0.77
Ortho2ExpressMatrix--a web server that interprets cross-species gene expression data by gene family information. BMC Genomics (2011) 0.77
The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates. J Mol Med (Berl) (2013) 0.77
Single-Incision Transumbilical Surgery (SITUS) versus Single-Port Laparoscopic Surgery and conventional laparoscopic surgery: a prospective randomized comparative study of performance with novices in a dry laboratory. World J Urol (2014) 0.77
The influence of left renal vein entrapment on outcome after surgical varicocele repair: a color Doppler sonographic demonstration. J Ultrasound Med (2004) 0.76
Pathway deregulation and expression QTLs in response to Actinobacillus pleuropneumoniae infection in swine. Mamm Genome (2014) 0.76
Preoperative hydronephrosis predicts advanced bladder cancer but is not an independent factor for cancer-specific survival after radical cystectomy. Urol Int (2010) 0.76
Treatment of severe bilateral nerve pain after Pfannenstiel incision. Urology (2006) 0.76
New findings in bladder and prostate cancer: highlights of the 22nd annual congress of the European association of urology, march 21-24, 2007, berlin, Germany. Rev Urol (2007) 0.75
New findings in prostate cancer: highlights from the 23rd annual congress of the European association of urology, march 26-29, 2008, milan, Italy. Rev Urol (2008) 0.75
Identification of QTL affecting resistance/susceptibility to acute Actinobacillus pleuropneumoniae infection in swine. Mamm Genome (2014) 0.75